mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.003 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.003 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.003 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.004 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.005 |